 public reporting on accesstomedicine public reporting on accesstomedicine 28 admin mon 10142019 1732 the initiative project particularly those developed by pharma companies publicly reports information on access to medicine the indicator helps to assess whether the initiative project is transparent about its activities regarding access to medicine additional qualitative reporting  official organization s report about its accounts or activities societal activities for example  information transparency   openly available and comprehensive information annual report sustainability report indicate whether or not the initiative project reports on access to medicine issues yes no yes no process n a annually annually data disclosed by company needs to be verified by an independent third party yes example on how gsk offers information on access to medicine extract from gsk esg performance summary 2018 p 2 extract from gsk esg performance summary 2018 p 3 available at  https wwwgskcom media 5308 esgperformancesummary2018pdf  companies should track progress in accesstomedicine outcomes against defined goals conduct impact assessments of access activities and make results publicly available transparency 